Expression of concern
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Paper Information
Record ID:
35178
Author(s):
Journal:
Publication Date:
March 17, 2021
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Gastroenterology, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Medicine, Division of Gastroenterology, Mater Dei Hospital, Msida, Malta cUniversity Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, and Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois CHUV, University Hospital Lausanne, Lausanne, Switzerland
- Department of Gastroenterology and Hepatology, CHU UCL Namur, Yvoir, Belgium
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven,Leuven, Belgium, and Department of Chronic Diseases, Metabolism and Ageing,TARGID-IBD, KU Leuven, Leuven, Belgium
- Infectious Diseases Service, Centro Hospitalar Universitario Sao Joao, Porto, Portugal, and Instituto de Inovacao e Investigacao em Saude [I3s], Faculty of Medicine, Department of Medicine, University of Porto, Portugal
- Gastroenterology Department, St James University Hospital, Leeds, UK
- Humanitas Clinical and Research Center – IRCCS -, Rozzano [Mi], Italy, and Humanitas University, Department of Biomedical Sciences Milan, Italy
- Hospital Universitari Mutua Terrassa, Digestive Diseases Department, Terrassa, Catalonia, and Centro de Investigación Biomedica en red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
- Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
- Department of Gastroenterology, Barts Health NHS Trust, Royal London Hospital, London, UK
- Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece
- Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Sorbonne Universite, INSERM, Institut Pierre Louis d’Epidemiologie et de Sante Publique, AP-HP, Hopital Saint- Antoine, Department of Gastroenterology, Paris, France
- Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- Gastroenterology Department, Centro Hospitalar Sao Joao, Porto, Portugal, and Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Portugal
- Outpatient Department of Gastroenterology, Department of Geriatrics, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Paediatric Gastroenterology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
- IBD Unit, Department of Gastroenterology, Hospital Clinico San Carlos and Instituto de Investigacion del Hospital Clinico San Carlos [IdISSC], Madrid, Spain
- Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey
- Centre Hospitalier de l’Universite de Montreal [CHUM] Pharmacy Department and Faculty of Pharmacy, University de Montreal, Montreal, QC, Canada
- University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland
- Department of Infectious Diseases, Tourcoing Hospital, Tourcoing, France
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (338)
338
Total Citations307
Post-Retraction(90.8%)
30
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
2
Within 30 days
73
Within 1 year
156
After 2+ years
1254
Days since retraction (latest)
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease
Walter Fries, Giorgio Basile, Federica Bellone et al. (5 authors)
Cells
Open Access
Published: Jun 2023
3 citations
3 citations
518 days after retraction
Efficacy and Safety of Biological Therapies and Jak Inhibitors in Older Patients with Inflammatory Bowel Disease
Walter Fries, Giorgio Basile, Federica Bellone et al. (5 authors)
Unknown Journal
Open Access
Published: Jun 2023
2 citations
2 citations
500 days after retraction
Morbus Crohn Update
Andrea S. Kreienbuehl, Luc Biedermann
Schweizer Gastroenterologie
Open Access
Published: Jun 2023
499 days after retraction
Miliary Tuberculosis in a Patient With Ulcerative Colitis Treated With Tofacitinib
Shruti Verma, Arshdeep Singh, Chandan Kakkar et al. (6 authors)
ACG Case Reports Journal
Open Access
Published: Jun 2023
2 citations
2 citations
493 days after retraction
Impfungen bei gastroenterologischen Erkrankungen und Immunsuppression
Christoph Jochum
Gastroenterologie up2date
Published: Jun 2023
493 days after retraction
Inflammatory bowel disease is associated with an increased risk of adverse events in patients undergoing joint arthroplasty
Dongdong Xu, Cheng Ding, Tao Cheng et al. (5 authors)
Bone and Joint Research
Open Access
Published: Jun 2023
5 citations
5 citations
493 days after retraction
Incidence of Pneumonia, Related Hospitalization, and Mortality Among Younger Unvaccinated IBD Patients in a Nationwide Cohort
Nabeel Khan, Chinmay Trivedi, Yash Shah et al. (7 authors)
Journal of Clinical Gastroenterology
Published: May 2023
2 citations
2 citations
490 days after retraction
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease
Filipa Bordalo Ferreira, Maria Ana Rafael, Lúcia Coimbra et al. (11 authors)
Vaccine
Open Access
Published: May 2023
9 citations
9 citations
469 days after retraction
Boon or Bane? Anti-Tumor Necrosis Factor Therapy Complicated by <i>Listeria monocytogenes</i> Meningitis Culminating in Colectomy for Ulcerative Colitis
Ria Nagpal, H Ulaganathan, Khushal Khan et al. (4 authors)
Journal of Medical Cases
Open Access
Published: May 2023
462 days after retraction
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
Niloofar Khoshnam Rad, Homayoon Vahedi, Anahita Sadeghı et al. (10 authors)
Middle East Journal of Digestive Diseases
Open Access
Published: Apr 2023
3 citations
3 citations
461 days after retraction
Ulcerative colitis and its correlation with the incidence of colorectal cancer
Felix Ongko, Erwin Kurniawan Santosa, Edward Then et al. (5 authors)
Science Midwifery
Open Access
Published: Apr 2023
458 days after retraction
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease
Marco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone et al. (22 authors)
Frontiers in Medicine
Open Access
Published: Apr 2023
7 citations
7 citations
442 days after retraction
Consensus for criteria of running a pediatric inflammatory bowel disease center using a modified Delphi approach
Youyou Luo, Kaichun Wu, Sitang Gong et al. (21 authors)
World Journal of Pediatrics
Open Access
Published: Apr 2023
1 citation
1 citation
437 days after retraction
Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Jalpa Patel, Mohamed Noureldin, Dina Fakhouri et al. (8 authors)
Digestive Diseases and Sciences
Open Access
Published: Apr 2023
7 citations
7 citations
437 days after retraction
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD)
Mariabeatrice Principi, Fabio Salvatore Macaluso, Alessia Todeschini et al. (24 authors)
European Journal of Gastroenterology & Hepatology
Published: Apr 2023
3 citations
3 citations
435 days after retraction
Herpes simplex virus colitis mimicking acute severe ulcerative colitis: a case report and review of the literature
Marionna Cathomas, Robert Rosenberg, Emanuel Burri et al. (8 authors)
Journal of Surgical Case Reports
Open Access
Published: Apr 2023
3 citations
3 citations
432 days after retraction
Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease
Jessica A. Ulrich, Nawras W. Habash, Yasmine A. Ismail et al. (8 authors)
Clinical Gastroenterology and Hepatology
Open Access
Published: Mar 2023
9 citations
9 citations
431 days after retraction
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
Valérie Desmedt, Aranzazu Jauregui-Amezaga, Liselotte Fierens et al. (13 authors)
European Journal of Cancer
Published: Mar 2023
7 citations
7 citations
425 days after retraction
SURGICAL MANAGEMENT OF ADULT CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN’S DISEASE AND COLITIS (GEDIIB)
Gilmara Pandolfo Zabot, Ornella Sari Cassol, Abel Botelho Quaresma et al. (18 authors)
Arquivos de Gastroenterologia
Open Access
Published: Mar 2023
5 citations
5 citations
424 days after retraction
Letter: be careful of gastrointestinal <scp>CMV</scp> infection in adverse events from <scp>ICIs</scp> therapy in solid tumours
Paola Parente, Stefano Ascani, Brigida Anna Maiorano et al. (5 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Mar 2023
1 citation
1 citation
423 days after retraction
<i>Clostridioides difficile</i> aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment
Danfeng Dong, Tongxuan Su, Wei Chen et al. (10 authors)
Gut Microbes
Open Access
Published: Mar 2023
29 citations
29 citations
423 days after retraction
Letter: be careful of gastrointestinal <scp>CMV</scp> infection in adverse event from <scp>ICIs</scp> therapy in solid tumours—Authors' reply
E. Dahl, Osama Karim Abed, Jørgen Agnholt et al. (9 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Mar 2023
423 days after retraction
Adherence to Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Two-Year Prospective Portuguese Cohort Study
Cândida Abreu, António A. Martins, Fernando Oliveira e Silva et al. (8 authors)
Vaccines
Open Access
Published: Mar 2023
4 citations
4 citations
420 days after retraction
Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Andreia Albuquerque, Carmelina Cappello, Oliver Stirrup et al. (4 authors)
Journal of Crohn s and Colitis
Open Access
Published: Mar 2023
8 citations
8 citations
417 days after retraction
Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
Flora Maria Lorenzo Fortes, Raquel Rocha, Genoile Oliveira Santana
World Journal of Gastroenterology
Open Access
Published: Mar 2023
6 citations
6 citations
407 days after retraction
Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data
Elizaveta Makarova, Aygul Khabirova, Н. И. Волкова et al. (8 authors)
World Journal of Clinical Pediatrics
Open Access
Published: Mar 2023
8 citations
8 citations
406 days after retraction
68 - PAPEL DEL HLA DQA1*05 EN LA RESPUESTA A TRATAMIENTO BIOLÓGICO CON ANTI-TNF EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL
Andrea Pascual Oliver, Camila Cuaran Cetina, Diego Casas Deza et al. (7 authors)
Gastroenterología y Hepatología
Open Access
Published: Mar 2023
401 days after retraction
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases
Paulina Núñez, Rodrigo Quera, Andrés Yarur
Drugs
Open Access
Published: Mar 2023
56 citations
56 citations
401 days after retraction
Performance of Cytomegalovirus Real-Time Polymerase Chain Reaction Assays of Fecal and Plasma Specimens for Diagnosing Cytomegalovirus Colitis
Onuma Sattayalertyanyong, Julajak Limsrivilai, Phutthaphorn Phaophu et al. (10 authors)
Clinical and Translational Gastroenterology
Open Access
Published: Feb 2023
7 citations
7 citations
400 days after retraction
Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
Ashkan Rezazadeh Ardabili, Dirk van Esser, D Wintjens et al. (14 authors)
Journal of Crohn s and Colitis
Open Access
Published: Feb 2023
1 citation
1 citation
388 days after retraction
Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis
Dorina Bajzát, A.F. Kéri, Marcell Imrei et al. (9 authors)
Inflammatory Bowel Diseases
Published: Feb 2023
3 citations
3 citations
387 days after retraction
Review of the safety with biologics in inflammatory bowel disease
Andrea Pascual, Raquel Vicente, Eva Sierra et al. (4 authors)
Journal of IMIDs
Open Access
Published: Feb 2023
379 days after retraction
Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
Si Yu, Xiaomeng Ge, Hui Xu et al. (10 authors)
Frontiers in Cellular and Infection Microbiology
Open Access
Published: Feb 2023
16 citations
16 citations
378 days after retraction
High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
Bhaskar Kante, Sudheer K. Vuyyuru, Ritu Gupta et al. (12 authors)
Indian Journal of Gastroenterology
Open Access
Published: Feb 2023
2 citations
2 citations
373 days after retraction
Management of inflammatory bowel disease in the elderly: A review
Paula Sousa, Lorenzo Bertani, Cláudio Rodrigues
Digestive and Liver Disease
Open Access
Published: Jan 2023
19 citations
19 citations
361 days after retraction
Vaccines in Children Exposed to Biological Agents<i>In Utero</i>and/or During Breastfeeding: Are They Effective and Safe?
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis
Published: Jan 2023
17 citations
17 citations
357 days after retraction
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
Takashi Ishige, Toshiaki Shimizu, Kenji Watanabe et al. (32 authors)
Journal of Gastroenterology
Open Access
Published: Jan 2023
4 citations
4 citations
352 days after retraction
Telenutrition for the management of inflammatory bowel disease: Benefits, limits, and future perspectives
Merve Guney-Coskun, Ezgi Kolay, Metin Başaranoğlu
World Journal of Clinical Cases
Open Access
Published: Jan 2023
10 citations
10 citations
352 days after retraction
Inflammatory bowel disease complicated with rare pathogen infection
Jiaheng Fang, Guoxiong Li
Shijie huaren xiaohua zazhi
Open Access
Published: Jan 2023
348 days after retraction
Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics
Yana Ma, Jingjie Zhao, Liangliang Cheng et al. (10 authors)
Carbon
Published: Jan 2023
83 citations
83 citations
347 days after retraction
Outcome of inflammatory bowel disease patients with prior malignancy
Uria Shani
Annals of Gastroenterology
Open Access
Published: Jan 2023
1 citation
1 citation
342 days after retraction
Coronavirus disease 2019 and gastrointestinal disorders in children
Anna Röckert Tjernberg, Petter Malmborg, Karl Mårild
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2023
5 citations
5 citations
342 days after retraction
The inflammatory bowel disease care manager: Italian state of the art
Daniele Napolitano, Federica Di Vincenzo, Nicoletta Orgiana et al. (7 authors)
Annals of Gastroenterology
Open Access
Published: Jan 2023
1 citation
1 citation
342 days after retraction
Is cervical dysplasia a major concern in women with inflammatory bowel disease?. A spanish retrospective study
Lorena Jara Fernández, Juan Ángel Ferrer, J L Pérez Calle et al. (4 authors)
Revista Española de Enfermedades Digestivas
Open Access
Published: Jan 2023
342 days after retraction
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
Piotr Eder, Michał Łodyga, Magdalena Gawron-Kiszka et al. (14 authors)
Gastroenterology Review
Open Access
Published: Jan 2023
32 citations
32 citations
342 days after retraction
Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn’s Disease: Patient Selection and Reported Outcomes
Sara Horst, Raymond Cross
Drug Design Development and Therapy
Open Access
Published: Jan 2023
11 citations
11 citations
342 days after retraction
Besondere Behandlungssituationen: Malignome und opportunistische Infektionen
Wolfgang Reindl
Springer eBooks
Published: Jan 2023
342 days after retraction
Active tuberculosis in inflammatory bowel disease patients: a case–control study
Matheus Freitas Cardoso de Azevedo, Luísa Leite Barros, Filipe Fernandes Justus et al. (11 authors)
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2023
3 citations
3 citations
342 days after retraction
Systematic review with network meta‐analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease
Shahida Din, Christian P. Selinger, Christopher J. Black et al. (4 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Dec 2022
50 citations
50 citations
341 days after retraction
Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group
Way Seah Lee, Katsuhiro Arai, George Alex et al. (10 authors)
Journal of Gastroenterology and Hepatology
Open Access
Published: Dec 2022
10 citations
10 citations
338 days after retraction
Quick Stats
Total Citations:
338
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025